Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sire Bioscience Inc. C.SIRE

Healthcare Drug Manufacturers - Major Cannabis
SIRE BIOSCIENCE is a Life Science company and a Health Canada License holder under the Cannabis Act and the Industrial Hemp Regulations. SIRE owns 50 Acres of prime agricultural land in Leamington, ON, consisting of 137,000 sq ft greenhouse.


CSE:SIRE - Post by User

Sire Bioscience Inc.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(6)
•••
Post by IntelInvestoron Jan 11, 2021 1:09pm
203 Views
Post# 32267892

Suport at 50-day moving average line

Suport at 50-day moving average lineToday Sire Bioscience is bouncing off its 50-day moving average line.

TradingView

The most recent Morningstar's quatitative fair value for this stock is $0.14.  That is 40% higher than the current price of $0.10.

GLTA!
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities